Professor Antonio Ceriello is Head of the Research Department on Diabetes and CVD at the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain and Coordinator of Diabetes Project at IRCCS MultiMedica, Milan, Italy. Until 2006 he was Chair of Endocrinology and Director of the School of Specialty in Geriatrics at the University of Udine, Italy, and from 2006 to 2009 Professor of Endocrinology at the University of Warwick, UK. From 2004 to 2006 he also was Adjunct Professor of Internal Medicine at the Oklahoma City University, U.S.A. Professor Ceriello has published widely in the area of diabetes with over 400 original papers and several book chapters. His current h-index is 78. Prof. Ceriello has been consultant of the National Institutes of Health, U.S.A. for the program of the research 2003-2005, related to cardiovascular disease and type 1 diabetes, and member of the writing committee of the American Heart Association of the guidelines on “Acute Hyperglycemia and Acute Coronary Syndromes”. He has also chaired the International Diabetes Federation (IDF) committee for the development in 2008, and in the 2011 for the update of “Guideline for Management of Postmeal Glucose ”. Currently, is the President of the European Association for the Study of Diabetes (EASD) Study Group on “Diabetes and Cardiovascular Diseases”. He also served as Review of the 2012 “European Guidelines on Cardiovascular Disease Prevention in Clinical Practice” and for the 2013 “European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD “. From 2009 to 2012 he has been member of the Board of the IDF Europe and Consultant of the EU Commission for the Framework “Diabetes as a model of chronic care management”. He also served as Associate Editor of “Diabetes Care” from 2003 to 2011 and Associate Editor of “Diabetic Medicine” from 2005 to 2016. From July 1st 2016 he has been appointed as Editor in Chief of of “Diabetes Research and Clinical Practice”, the official IDF journal. Prof. Ceriello is the winner in the 1984 of the “Italian Annual Award for Young Researcher”, in the 1990 of the “National Award for Research on the Pathophysiology of Diabetic Complications”, in the 1998 of the “National Award Italian Society of Diabetology” and in the 2004 of the “Camillo Golgi Prize” of the EASD. Currently is serving as Referee of European Commission for the 2017 grant program regarding diabetes of the HORIZON 2020 Program.
Dr. Eberhard Standl
Dr. Eberhard Standl is Professor of Medicine, endocrinologist and angiologist at the Munich Diabetes Research Group/Diabetes Research Institute. He graduated from the Universities of Munich and Frankfurt, and has developed his career in both Munich, and at the Joslin Diabetes Center, Boston, USA. He is retired director of the Department of Endocrinology, Diabetology and Metabolism at the Academic Hospital Munich-Schwabing. Professor Dr. Standl's principal areas of research are diabetology, micro- and macrovascular disease, cardioneuropathy, action and degradation of insulin, and epidemiology of cardiovascular diabetic complications. He has published some 560 original papers, review articles, textbook chapters and monographs, and has received various scientific awards, including the Bertram Award for research related to vascular disease in diabetes in 1981, the Castelli-Pedroli Prize of the European Association for the Study of Diabetes (EASD) in 1999, the Harold Rifkin Award of the American Diabetes Association 2005, and the Albert Renold Medal of EASD 2006. He is a member of several scientific associations, with strong affiliations to the German Diabetes Association, the EASD, and the International Diabetes Federation (IDF). He was president of the German Diabetes Association 1988/89, vicepresident both of EASD and IDF 2003 to 2006 and chairman of the Organizing Committee for the EASD congress 2004 in Munich. He is vicechair of the newly founded EASD study group on cardiovascular complications, and immediate Past-President both of the German Diabetes Union and of IDF Europe.
Dr Hisham Maksoud
MB BCh BAO LRCP & SI (NUI) FRCP (Edinburgh) FRCP (London) FACE MD
Training:My training at the Oxford teaching hospitals included: diabetes (type 1, type 2, impaired glucose tolerance, juvenile, antenatal diabetes), endocrine disease, PCOS, impotence, hirsutism, dyslipidaemia, thyroid cancer, osteoporosis, Paget's Disease, osteogensis imperfecta, premature menopause, multiple endocrine neoplasia syndromes, carcinoid and diagnostically difficult syndromes. For my Doctorate of Medicine I worked on new therapy for Type 2 Diabetes (GLP-1 and oral insulin therapy) at the Diabetes Research Laboratories, Oxford
Clinics:General medicine, diabetes mellitus, endocrine disease, impotence (erectile dysfunction), thyroid disorders, obesity (over weight), diabetes in pregnancy, diabetes in children and adolescence, PCOS, endocrine hypertension (high blood pressure), endocrine disorder in pregnancy, dyslipidemia (high cholesterol), osteoporosis, metabolic bone disease, parathyroid and calcium metabolism, chronic fatigue syndrome, pituitary disease, adrenal disease, hypoglycaemia, hyponatremia (low sodium), diabetic foot and thyroid cancer.
Previous Clinical Experience:•Radcliffe Infirmary, Oxford •John Radcliffe Hospital, Oxford •Churchill Hospital, Oxford •Nuffield Orthopaedic Hospital, Oxford
New Therapy of Type 2 Diabetes, Obesity, Impotence, Thyroid disease and PCOS
Membership of Professional Bodies:•American Association of clinical endocrinologists •American Diabetic Association •American Endocrine Society •British Endocrine Society •British Medical Association •Diabetes UK •European Association for the Study of Diabetes •Impotence Association •Pituitary Foundation •Royal College of Physicians, Edinburgh •Royal College of Physicians, London •Royal College of Surgeons in Ireland •The Association of Study of Obesity •UK Resuscitation Council
Dr Craston Bio : Dr Iain Cranston is a diabetes physician based in Portsmouth, UK. He has specialty responsibility for the delivery of technology-driven services (CSll / CGM etc.) to approximately 1% of the UK POPULATION. Alongside this, he is the lead diabetes clinician for the Wessex renal and transplant center, managing individuals with specific and high glycaemic risks. He has a background in clinical research obtained during his time at Guy’s and King’s College and ST. Thomas’ Hospitals, into impaired awareness of hypoglycemia in insulin-treated diabetes and the cerebral and endocrine mechanisms underlying the syndrome. For the last 20 years, Dr. Cranston Has been in practice with the goal of translating the lessons learnt from research into routine clinical care consultations. This has resulted in a focus on effective glucose monitoring strategies to underpin clinical decision-making and the development of data analytical processes to guide clinical consultations towards more effective therapeutic interventions in both type 1 and type 2 diabetes